Magnevist
In the US, Magnevist (gadopentetate dimeglumine systemic) is a member of the drug class magnetic resonance imaging contrast media and is used to treat CNS Magnetic Resonance Imaging and Vascular Magnetic Resonance Imaging.
US matches:
UK matches:
- MAGNEVIST INJECTION (Leaflet)
Ingredient matches for Magnevist
Gadopentetic Acid is reported as an ingredient of Magnevist in the following countries:
- Georgia
- Malta
- Romania
Gadopentetic Acid dimeglumine (a derivative of Gadopentetic Acid) is reported as an ingredient of Magnevist in the following countries:
- Argentina
- Australia
- Austria
- Belgium
- Bosnia & Herzegowina
- Bulgaria
- Canada
- China
- Colombia
- Costa Rica
- Croatia (Hrvatska)
- Denmark
- Dominican Republic
- Ecuador
- El Salvador
- Estonia
- Finland
- France
- Georgia
- Germany
- Greece
- Guatemala
- Honduras
- Hungary
- Iceland
- India
- Italy
- Japan
- Latvia
- Lithuania
- Luxembourg
- New Zealand
- Nicaragua
- Norway
- Oman
- Panama
- Peru
- Poland
- Russian Federation
- Serbia
- Slovenia
- South Korea
- Spain
- Sweden
- Switzerland
- Tunisia
- Turkey
- United Kingdom
- United States
- Vietnam
International Drug Name Search
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
